Clinical Trial Update: Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pelvic radiotherapy with concurrent neoadjuvant FOLFOX for newly diagnosed rectal adenocarcinoma; study terminated, results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Drugs mentioned

• FOLFOX

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Rectal Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-11-04